Clinical Trial: A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774403) titled 'A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization' on June 24.

Brief Summary: AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

Study Start Date: June 24

Study Type: INTERVENTIONAL

Condition: Bronchiectasis With Pseudomonas Aeruginosa Colonization

Intervention: DRUG: AZD0292

AZD0292 administered starting on Day 1 via IV infusion, subsequent administrations per schedule of assessments.

OTHER: Placebo

Placebo administered starting on Day 1 via IV infusion, subsequent admin...